Trump said so on Sunday (local time) at a press conference at the White House, shortly after the US drug authority reported to the FDA that it accelerated the use of convalescent plasma for the treatment of certain corona patients. Earlier in the day, the Washington Post reported that Trump was going to make the use of plasma therapy public.
“This is a powerful therapy,” the president told journalists about the treatment, which uses antibodies from the blood of donors who have already gone through the infection. “Today’s move will drastically increase access to this treatment,” Trump said.
Minister Alex Azar (Public Health) stated that more than 70,000 corona patients have now undergone plasma therapy and that the first research results show that the survival rate among people who received plasma was 35 percent higher.
Some experts believe the method may help fight the virus, but it is by no means a decisive breakthrough. Trump himself spoke of a “historic breakthrough” in the treatment of the lung virus that “will save countless lives.”
Research is also being carried out in the Netherlands with the support of the Sanquin blood bank, which purchases antibodies against corona for the development of a drug against Covid-19.
‘Our’ vaccine gaining momentum?
The Financial Times reported on Sunday that the Trump administration is considering accelerating an experimental vaccine from the British-Swedish pharmaceutical company AstraZeneca and the University of Oxford so that it can be used in emergencies in the US before the November 3 elections. . The Netherlands, among others, has already ordered millions of doses of the promising vaccine.